VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
出版年份 2016 全文链接
标题
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 46, Pages 13144-13149
出版商
Proceedings of the National Academy of Sciences
发表日期
2016-11-01
DOI
10.1073/pnas.1616168113
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
- (2016) Zhongwei Yin et al. Aging-US
- The pathogenesis and treatment of cardiac atrophy in cancer cachexia
- (2016) Kate T. Murphy AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications
- (2016) Marius R. Robciuc et al. Cell Metabolism
- The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells
- (2016) Zuyue Sun et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
- (2016) Seyyed Mohammad Reza Kazemi-Bajestani et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes
- (2016) Rui Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
- (2015) Frances Belmonte et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Molecular Controls of Arterial Morphogenesis
- (2015) M. Simons et al. CIRCULATION RESEARCH
- Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection
- (2015) Rosalinda Madonna et al. HEART FAILURE REVIEWS
- Simultaneous determination of doxorubicin and curcumin in rat plasma by LC–MS/MS and its application to pharmacokinetic study
- (2015) Wenzhuan Ma et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Intracoronary Cytoprotective Gene Therapy
- (2015) Felix Woitek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress
- (2015) Inês Marques-Aleixo et al. MITOCHONDRION
- Persistent γH2AX: A promising molecular marker of DNA damage and aging
- (2015) Mohammad Sabbir Siddiqui et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
- (2015) Anindita Das et al. PHARMACOLOGY & THERAPEUTICS
- VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
- (2015) Xiaojuan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Twisting and Ironing: Doxorubicin Cardiotoxicity by Mitochondrial DNA Damage
- (2014) K. C. Nitiss et al. CLINICAL CANCER RESEARCH
- VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
- (2014) Riikka Kivelä et al. EMBO Molecular Medicine
- Cardiomyopathy Associated With Cancer Therapy
- (2014) Anthony F. Yu et al. JOURNAL OF CARDIAC FAILURE
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular remodelling in coronary artery disease and heart failure
- (2014) Gerd Heusch et al. LANCET
- Vascular Endothelial Growth Factor-B in Physiology and Disease
- (2014) Maija Bry et al. PHYSIOLOGICAL REVIEWS
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Low Levels of Vascular Endothelial Growth Factor B Predict Left Ventricular Remodeling After Acute Myocardial Infarction
- (2012) Yvan Devaux et al. JOURNAL OF CARDIAC FAILURE
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Cardiovascular Disease and mTOR Signaling
- (2012) Zhao Zhong Chong et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Chipster: user-friendly analysis software for microarray and other high-throughput data
- (2011) M Aleksi Kallio et al. BMC GENOMICS
- Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
- (2010) Maija Bry et al. CIRCULATION
- Intramyocardial VEGF-B 167 Gene Delivery Delays the Progression Towards Congestive Failure in Dogs With Pacing-Induced Dilated Cardiomyopathy
- (2010) Martino Pepe et al. CIRCULATION RESEARCH
- Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction
- (2010) Yvan Devaux et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2010) Imke Albrecht et al. PLoS One
- The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice
- (2009) Jenni Huusko et al. CARDIOVASCULAR RESEARCH
- Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction
- (2009) Lorena Zentilin et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started